Life sciences

#Cell therapy #Diabetes #Drug development #Immunology #Life sciences

Dundee professor joins GSK’s Immunology Network 

Professor of Cellular Immunology at the University of Dundee’s School of Life Sciences, Doreen Cantrell, has been selected to join GSK’s Immunology Network, a programme designed to embed academic scientists in GSK laboratories with the goal to broaden scientific insight and drive major breakthroughs in applied immunology. … Read More

#News

#AI #Biotechnology #Chemistry #Digital #Drug discovery #Life sciences

Digital Science launches research platform 

Digital Science has launched a new version of its Dimensions platform - Dimensions Life Sciences & Chemistry - focused on life sciences and chemistry research activities.   Dimensions L&C analyses more than 120 million scientific publications, millions of patents, grants and clinical trial documents. It applies semantic text analysis tools and ontologies, providing… Read More

#Business & Investment

#Biomedicine #Digital focus #Gene therapy #Life sciences #MS #Narrated podcasts

Streamlining gene therapy and how MS provides information on virus structure

In this podcast, Megan Thomas narrated two articles in which Akash Bhattacharya, the Senior Application Scientist at Beckman Coulter Life Sciences, explains how streamlining gene therapy manufacturing will help products reach more patients, and Andreas Huhmer, Senior Director of Proteomics and Metabolomics at Thermo Fisher Scientific, discusses the value of… Read More

#Podcasts

#Biomanufacturing #Corning Life Sciences #Drug discovery #Immunology / Virology & Vaccines #Life sciences #SARS-CoV-2

Optimising vaccine production through customisation

Listen to this article on the DDW Podcast: An expert’s view by John Yoshi Shyu, Ph.D. Corning Life Sciences. Most vaccines are manufactured using technology devised fifty or more years ago, in manufacturing plants that are sometimes even older. The vaccine production process is continually refreshed by new tools and technologies,… Read More

#Business & Investment #Editor's Choice #Exclusive Content #News

#Biomedicine #Collaboration #Life sciences #Pharma

Stop, collaborate and listen: podcast

This is the latest episode of the free DDW podcast, “Stop, collaborate and listen: a model for successful pharma and vendor engagement”. It covers a narrated article written for DDW and read aloud by Megan Thomas. Digital transformations are having wide-ranging and profound impacts within life sciences, creating both opportunities… Read More

#Editor's Choice #News

#Biomedicine #Digital focus #Life sciences #Narrated podcasts

A model for successful pharma and vendor engagement

Digital transformations are having wide-ranging and profound impacts within life sciences, creating both opportunities and challenges. One of those challenges is adopting new software systems to drive the transformations. A team from Novartis Institutes of BioMedical Research (NIBR) recognised the need to ensure a good user experience for their in… Read More

#Podcasts

#Drug development #Infectious diseases #Life sciences #Precision medicine #Research

Cerba Research awarded NIH contract for lab services

Cerba Research has been awarded a five-year contract for Clinical Central Laboratory Services from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH). Findings from this research are said to be vital to NIAID’s efforts to advance vaccines, drugs, and diagnostic… Read More

#News

#Biologics / Biotechnology #Biotechnology #Covid-19 #Life sciences #Public health

Europe’s emerging biotechs: Challenges, opportunities and funding

Listen to this article on the DDW Podcast: John Macdonald is Vice President, Venture & Financial Alliances at ICON. He examines the European biotech sector – its expertise and opportunities and potential for growth. By harnessing biological processes on a cellular and biomolecular level, biotech is benefitting industries as varied as… Read More

#Business & Investment #Covid-19 #Editor's Choice #Exclusive Content #Market Reports #News #Opinion

#Assays #Biotechnology #Life sciences #Therapeutics

PerkinElmer expands KRAS oncology drug discovery assays

PerkinElmer has released four new ready-to-use AlphaLISA KRAS kits, designed to help scientists better understand complex KRAS protein structures and mutations so they can more easily, quickly, and precisely identify potential new therapeutic candidates for a wide range of prevalent cancers. Researchers will now be able to choose between PerkinElmer’s… Read More

#News

Business agreement
#Antibodies #Bioproduction #Flow Cytometry #Life sciences #Proteogenomics #Reagents

PerkinElmer to acquire BioLegend

PerkinElmer has entered into an agreement to acquire BioLegend, provider of life science antibodies and reagents, for approximately US$5.25 billion. The transaction will be the largest in PerkinElmer’s history and is expected to close by the end of the 2021 calendar year, subject to regulatory approvals and other customary closing… Read More

#News

#Biochemistry #Drug development #Drug discovery #Life sciences #Microfluidics #Pharmaceuticals

Researchers develop tool to speed up the study of enzymes

Scientists understand that transformations that couldn’t historically be explained by conventional chemistry or physics alone are in fact powered by enzymes – protein molecules comprised of chains of amino acids that act to speed up, or catalyse, the conversion of one kind of molecule (substrates) into another (products). While more… Read More

#News

#Data #Drug discovery #Drug innovation #Life sciences

Paradigm4 launches multi-omics app for advanced cross-study analysis

Paradigm4 has launched Reveal: Multi-Omics, an app which allows researchers to undertake advanced, cross-study analyses and enable quick searches for genes and proteins across integrated public reference and proprietary datasets. It is built on top of Paradigm4’s SciDB analytics platform, designed for rapid data slicing that enables scientific data modelling,… Read More

#News

#Bioscience #Biotechnology #Cell and gene therapy #Cell and Gene Therapy Catapult #Drug development #Life sciences #Research

GSK unveils plan for one of Europe’s largest life science campuses

GSK has announced that it planning to develop its research & development site in Stevenage, UK,  into one of Europe’s largest clusters for biotechnology and early-stage life science companies. The concept has been developed in partnership with Stevenage Bioscience Catalyst (SBC), among others and would build on GSK’s existing presence,… Read More

#News

#Covid-19 #Investment #Life sciences #Public health #Social enterprise

Mologic becomes a ‘social enterprise’ following acquisition

A group of philanthropic funds and investors led by the Soros Economic Development Fund (SEDF), with support from the Bill & Melinda Gates Foundation, has launched Global Access Health (GAH), a social enterprise that aims to expand access to affordable medical technology. The group has financed the acquisition of Mologic,… Read More

#News

#Automated workflows #Biotechnology #Life sciences #Research #Webinar

Multimodal zebrafish workflows on a confocal imaging reader: webinar

Join this BioTek webinar to learn how quantitative phenotypic analysis is central to many zebrafish research workflows. Phenotypic analysis often involves leveraging multiple technologies for molecular, cellular and organismal-level evaluations. Accordin to Biotek, the new Cytation C10 confocal imaging reader is a powerful single-instrument solution for multimodal plate reading,… Read More

#News